Benign Skin Tumours
Benign Skin Tumours
Benign Skin Tumours
Diagnosis
Assess the history of the lesion's appearance and growth.
Carefully examine the lesion. Allow the appropriate time, light and perhaps magnification, to identify
such tumours correctly.
Have sufficient knowledge to differentiate these from skin cancers and particularly malignant skin
tumours.
Be aware of the limits of one's knowledge in this field.
Consider the amount of sun exposure the patient is generally subjected to (eg, people who work
mainly outside) and the site of the lesion (cancers are more likely on sun-exposed areas, such as the
face). [1]
Refer for diagnosis or biopsy lesions where there is any uncertainty of their nature. See the National
Institute for Health and Care Excellence (NICE) guidance - under 'Referral', below.
Experience in Australia, the country with the world's highest incidence of skin cancer, shows that adequately
trained primary care practitioners in open-access skin cancer clinics can diagnose a wide range of skin lesions,
with high specificity and moderate-to-high sensitivity. [2] A 2008 study was critical of minor surgery in the UK and
suggested there was room for improvement. [3] A useful approach is to subdivide lesions into the categories
below and diagnosis on the basis of further discriminating features.
Macular or slightly raised (papular) lesions.
Frankly papular lesions.
Lesions beneath the epidermis (not related to bony or deeper structures).
It must be borne in mind that such a schema works only for common benign skin lesions and that there are many
rarer lesions that will present differently. If the diagnosis is unclear, or the lesion has an atypical appearance,
dermatological referral and/or biopsy of the lesion should be considered.
The tumours listed do not include the full range of benign dermatoses which produce skin lesions but not
necessarily skin tumours (for example, psoriasis, acne vulgaris, discoid lupus erythematosus, neurofibromatosis,
pyoderma gangrenosum, necrobiosis lipoidica diabeticorum and many others).
Page 2 of 7
There is a great deal of variability in size, shape and amount of hair present. Naevomelanocytic naevi
are the most common and are categorised into three different subtypes:
The junctional naevi are characterised by melanocytic proliferation limited to the basal
epidermis with minimal elevation.
The compound naevus is believed to represent an intermediate step in the evolution of the
melanocytic naevus. Components of both dermal and junctional naevi are found
simultaneously.
Intradermal naevi are the most common type of adult naevus. These may be papillary,
pedunculated, or flat and are often hairy. They are often multiple. The melanocytes in this
subtype are entirely within the dermis and have irregular margins. While the junctional
naevus can have a reputation for degeneration into malignant melanoma, the intradermal
naevus does not.
Special subtypes include the blue naevus:
These are discrete lesions located in the head and neck (occasionally on the arms). One
variety (cellular blue naevus) occurs on the buttock and sacrococcygeal areas.
The blue naevus has abundant melanin pigment. It is located entirely within the dermis and
no epidermal or junctional component is present.
They can be misdiagnosed as benign fibrous histiocytomas.
A malignant variant of the blue naevus does exist.
Dermatofibroma
Dermatofibroma are considered to be a benign tumour, or may represent a fibrous reaction to minor
trauma and insect bites.
They are firm raised papules or nodules. They vary in colour from brown to purple and red.
They occur anywhere but are seen most commonly on the lower limb. Fitzpatrick's sign may be used
to aid diagnosis (dimpling of the lesion beneath the skin when subject to bilateral compression, ie
gently pinching the lesion on either side).
The lesions may resemble melanomas, so biopsy may be necessary to confirm the diagnosis.
Occasionally the lesion may be removed for cosmetic reasons.
Multiple dermatofibromas may be seen in association with autoimmune disorders such as systemic
lupus erythematosus, or in patients who are immunocompromised.
Page 3 of 7
The incidence of the lesions increases with age.
They may be mistaken for melanomas, although melanomas have a greater range of colour.
They are usually asymptomatic but may itch or become inflamed after friction from clothing.
Biopsy should be undertaken if the diagnosis is in any doubt.
They may be treated for cosmetic reasons with cryotherapy.
A sudden onset or increase in the number of lesions may signal an underlying malignancy, usually of
the stomach, colon or breast - this is known as the Leser-Trlat sign, a paraneoplastic dermatosis.
Occasionally, the sign is seen in people who have no detectable malignancy. [6] [7]
Keratoacanthomas
Keratoacanthomas are rapidly growing papular lesions, often with a central umbilicated keratinous
core which may be expelled after several weeks, leaving a hypopigmented scar.
They are usually single and occur in sun-exposed areas, mainly in older patients.
Total excision is the treatment of choice, as they are histologically similar to squamous cell carcinoma
and tend to leave a prominent scar after they have undergone spontaneous involution. Smaller lesions
can be treated with electrodesiccation and curettage or blunt dissection.
Radiotherapy is an option for patients with recurrence or large lesions.
Page 4 of 7
Intralesional fluorouracil is a treatment option where there is a large lesion in an area on which it would
be difficult to achieve excision with a good cosmetic result - eg, the eyelids or nasolabial fold. [8]
Page 5 of 7
Pyogenic granuloma
Pyogenic granuloma are also known as granuloma telangiectaticum and an association with trauma is
frequent.
They are rapidly proliferating solitary lesions with a tendency to bleed. They are usually less than 1 cm
in diameter.
Excision biopsy is usually recommended.
Cutaneous horn
This is also known as cornu cutaneum.
It is a feature of hyperkeratotic lesions including actinic keratosis, seborrhoeic keratosis, verrucae and
epidermoid carcinoma.
Trichoepithelioma
These are uncommon pink or flesh-coloured benign lesions on the face and scalp (occasionally the
trunk and neck).
They appear during adolescence and may be familial.
They should be treated with complete surgical excision.
Page 6 of 7
Pilomatrixoma
This is an uncommon variation of the epidermal cyst occurring on the neck, head and arms of children
and young adults.
It typically presents as a solitary subcutaneous nodule with attachment to the skin. There is a history of
episodes of inflammation and pain.
Treatment is by excision. The capsule is very friable.
A rare malignant form exists (the malignant pilomatrixoma or pilomatrix carcinoma).
Pseudoepitheliomatous hyperplasia
It can be difficult to distinguish from squamous carcinoma.
Another term for this lesion is pseudocarcinomatous hyperplasia.
An important feature is a history of trauma and irritation.
A conservative approach is warranted but, if there is any doubt, treat it as for squamous carcinoma
with appropriate margins of excision.
Referral
It is worth considering NICE guidance on referral if cancer is suspected: [10]
Refer a patient presenting with skin lesions suggestive of skin cancer or in whom a biopsy has
confirmed skin cancer to a team specialising in skin cancer.
Malignant melanoma of skin:
Skin lesion (pigmented and suspicious) with a weighted 7-point checklist score of 3 or
more: refer people using a suspected cancer pathway referral (for an appointment within
two weeks).
Skin lesion (pigmented or non-pigmented) that suggests nodular melanoma: consider a
suspected cancer pathway referral (for an appointment within two weeks).
Squamous cell carcinoma:
Skin lesion that raises the suspicion of a squamous cell carcinoma: consider a suspected
cancer pathway referral (for an appointment within two weeks).
Basal cell carcinoma:
Skin lesion that raises the suspicion of a basal cell carcinoma: consider routine referral.
Only consider a suspected cancer pathway referral (for an appointment within two weeks) if
there is particular concern that a delay may have a significant impact, because of factors
such as lesion site or size.
Page 7 of 7
9. Evans DG, Farndon PA; Nevoid Basal Cell Carcinoma Syndrome. Gene Reviews, June 20, 2002; Last Update: March 7,
2013
10. Suspected cancer: recognition and referral; NICE Clinical Guideline (2015)
Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical
conditions. EMIS has used all reasonable care in compiling the information but make no warranty as to its
accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions.
For details see our conditions.
Original Author:
Dr Sean Kavanagh
Current Version:
Dr Colin Tidy
Peer Reviewer:
Dr John Cox
Document ID:
1641 (v25)
Last Checked:
23/10/2015
Next Review:
21/10/2020